Description: This was a review of a June 4, 2013 SOA webinar. Jerry Enoch was the moderator. Presenters were Mark Birdsall, Mike Boerner, and Perry Kupferman, regulatory actuaries with Kansas, Texas, and California. The intent was to improve communications between small company actuaries and regulators by clarifying expectations and addressing some issues. ORSA and AG38 were mentioned but the focus was on current Appointed Actuary filings and future PBR requirements.

Description: From the 1985 Valuation Actuary Symposium A review of the process involved in making an actuarial opinion and in developing the related actuarial report to management. This was accomplished through a case study approach, specifically covering a universal life product.

Description: This session from the 1983 SOA Hollywood, Florida Meeting reviews life insurance company financial reporting including financial reporting developments in Canada and the U.S., recent accounting developments for non-guaranteed premium products and new issues relating to the U.S. statutory actuarial opinion. From Record of Society of Actuaries Vol. 9, No. 4.

Description: Preparing an effective actuarial memorandum in support of the health actuarial opinion.

Description: A discussion of funding arrangements that can reduce the costs of providing medical coverage through lower reserves or state tax savings, instead of through cutting benefits.

Description: The September 2014 Issue of the Financial Reporting Section's newsletter, The Financial Reporter

Description: Results of an industry survey on life insurance companies' efforts to implement the recently adopted Life Risk-Based Capital Phase II Instructions, which include new requirements for variable annuity contracts. Adopted by the NAIC on October 14, 2005, the new requirements are effective for year-end 2005. Also discusses a summary of the requirements set forth in the instructions.

Description: The arrival of ASU 2018-12 (a.k.a Targeted Improvements to the Accounting for Long-Duration Contracts or GAAP Targeted Improvements) presents insurers with augmented financial reporting risk across all areas of the valuation process. Naturally, the internal control frameworks that serve to mitigate these risks must evolve and expand. Valuation actuaries should view this transformative event as an opportunity to take an active role in developing new and improved controls that are both effective and sustainable.

Description: From the 1985 Valuation Actuary Symposium. Discussion on the role of valuation actuary.